Entering text into the input field will update the search result below

Viela Bio soars 24% on being acquired by Horizon Therapeutics

  • Horizon Therapeutics (NASDAQ:HZNP) and Viela Bio (NASDAQ:VIE), up 24% premarket ink agreement under which Horizon will acquire all of the issued and outstanding shares of Viela Bio common stock for $53.00/share in cash, representing a fully diluted equity value of ~$3.05B.
  • The

Recommended For You

Related Stocks

SymbolLast Price% Chg
HZNP
--
VIE
--